Kava-based supplement
Term · Oncology and biomedicine · MLC-T-ONC-014635
A Kava supplement derived from Piper methysticum, with potential cancer preventative activity. Upon oral administration, the kava-based supplement may affect the metabolism of certain carcinogens, presumably because of the kavalactones present in this product.
| Identifier | MLC-T-ONC-014635 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Kavalactones-based supplement |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014635",
"term": "Kava-based supplement",
"field": "Oncology and biomedicine",
"definition": "A Kava supplement derived from Piper methysticum, with potential cancer preventative activity. Upon oral administration, the kava-based supplement may affect the metabolism of certain carcinogens, presumably because of the kavalactones present in this product.",
"synonyms": [
"Kavalactones-based supplement"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/kava-based-supplement/"
}
Record 9,741 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.